SiCKO passed over at Oscars

Share this article:
No Oscar nod for Moore flick
No Oscar nod for Moore flick
There was no gold statuette for Michael Moore's SiCKO at this week's 80th Annual Academy Awards.

Moore's attack on the American health care system was nominated for best documentary feature, but the award went to “Taxi to the Dark Side,” a look at the death of a taxi driver in Afghanistan in US custody in Afghanistan.

Moore caused a stir throughout the industry early in the film's production as he vowed to take on Big Pharma and sought doctors and drug reps to interview.

The final result however took aim mainly at insurance companies and called for government-run healthcare instead of assaulting Big Pharma directly. The film took only brief swipes at the pharma industry, mostly through its portrayal of PhRMA CEO Billy Tauzin and his dealings with the pharmaceutical lobby.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...